Clinical Trial Update: Dual Algorithm Post Market Clinical Study

View source ↗

Summary

Post-market clinical study update for MP Biomedicals' Dual Algorithm evaluating its use in HTLV-I and HTLV-II infections and related HTLV-1 diseases. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-1 Associated Myelopathy Tropical Spastic Paraparesis
• Human T-lymphotropic Virus Type Ii Infection
• Human T-lymphotropic Virus Type Infection
• T-cell Leukemia Lymphoma

Snippet

Sponsor: MP Biomedicals, LLC | Conditions: HTLV-I Infections, HTLV-II Infections | Status: COMPLETED